(Mark One)
|
|
[ x ]
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
|
For the quarterly period ended June 30, 2014
|
|
|
|
[ ]
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
|
For the transition period from _____________ to _____________
|
Maryland
|
|
62-1470956
|
(State or other jurisdiction of incorporation or organization)
|
|
(I.R.S. Employer Identification No.)
|
|
|
|
222 Robert Rose Drive, Murfreesboro, Tennessee
|
|
37129
|
(Address of principal executive offices)
|
|
(Zip Code)
|
(615) 890-9100
|
(Registrant's telephone number, including area code)
|
Large accelerated filer [ x ]
|
|
Accelerated filer [ ]
|
Non-accelerated filer [ ]
|
|
Smaller reporting company [ ]
|
(Do not check if a smaller reporting company)
|
|
|
|
Page
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
June 30,
2014 |
|
December 31,
2013 |
||||
|
(unaudited)
|
|
|
||||
Assets:
|
|
|
|
||||
Real estate properties:
|
|
|
|
||||
Land
|
$
|
93,950
|
|
|
$
|
91,770
|
|
Buildings and improvements
|
1,374,727
|
|
|
1,320,567
|
|
||
Construction in progress
|
13,973
|
|
|
9,665
|
|
||
|
1,482,650
|
|
|
1,422,002
|
|
||
Less accumulated depreciation
|
(193,018
|
)
|
|
(174,262
|
)
|
||
Real estate properties, net
|
1,289,632
|
|
|
1,247,740
|
|
||
Mortgage and other notes receivable, net
|
60,854
|
|
|
60,639
|
|
||
Investment in preferred stock, at cost
|
38,132
|
|
|
38,132
|
|
||
Cash and cash equivalents
|
7,157
|
|
|
11,312
|
|
||
Marketable securities
|
13,991
|
|
|
12,650
|
|
||
Straight-line rent receivable
|
27,181
|
|
|
18,691
|
|
||
Equity-method investment and other assets
|
46,180
|
|
|
66,656
|
|
||
Total Assets
|
$
|
1,483,127
|
|
|
$
|
1,455,820
|
|
|
|
|
|
||||
Liabilities and Equity:
|
|
|
|
||||
Debt
|
$
|
638,019
|
|
|
$
|
617,080
|
|
Real estate purchase liabilities
|
4,000
|
|
|
2,600
|
|
||
Accounts payable and accrued expenses
|
11,084
|
|
|
8,011
|
|
||
Dividends payable
|
25,452
|
|
|
24,293
|
|
||
Lease deposit liabilities
|
22,775
|
|
|
22,775
|
|
||
Deferred income
|
1,415
|
|
|
3,901
|
|
||
Total Liabilities
|
702,745
|
|
|
678,660
|
|
||
|
|
|
|
||||
Commitments and Contingencies
|
|
|
|
||||
|
|
|
|
||||
National Health Investors Stockholders' Equity:
|
|
|
|
||||
Common stock, $.01 par value; 60,000,000 and 40,000,000 shares authorized;
|
|
|
|
||||
33,054,599 and 33,051,176 shares issued and outstanding, respectively
|
331
|
|
|
330
|
|
||
Capital in excess of par value
|
762,703
|
|
|
753,635
|
|
||
Cumulative dividends in excess of net income
|
969
|
|
|
3,043
|
|
||
Accumulated other comprehensive income
|
6,024
|
|
|
9,538
|
|
||
Total National Health Investors Stockholders' Equity
|
770,027
|
|
|
766,546
|
|
||
Noncontrolling interest
|
10,355
|
|
|
10,614
|
|
||
Total Equity
|
780,382
|
|
|
777,160
|
|
||
Total Liabilities and Equity
|
$
|
1,483,127
|
|
|
$
|
1,455,820
|
|
|
Three Months Ended
|
|
Six Months Ended
|
||||||||||||
|
June 30,
|
|
June 30,
|
||||||||||||
|
2014
|
|
2013
|
|
2014
|
|
2013
|
||||||||
|
(unaudited)
|
|
(unaudited)
|
||||||||||||
Revenues:
|
|
|
|
|
|
|
|
||||||||
Rental income
|
$
|
41,353
|
|
|
$
|
24,067
|
|
|
$
|
81,666
|
|
|
$
|
48,172
|
|
Interest income from mortgage and other notes
|
1,748
|
|
|
1,972
|
|
|
3,504
|
|
|
3,941
|
|
||||
Investment income and other
|
1,059
|
|
|
1,063
|
|
|
2,126
|
|
|
2,115
|
|
||||
|
44,160
|
|
|
27,102
|
|
|
87,296
|
|
|
54,228
|
|
||||
Expenses:
|
|
|
|
|
|
|
|
||||||||
Depreciation
|
9,540
|
|
|
4,391
|
|
|
18,777
|
|
|
8,639
|
|
||||
Interest, including amortization of debt discount and issuance costs
|
6,829
|
|
|
1,597
|
|
|
13,715
|
|
|
2,721
|
|
||||
Legal
|
10
|
|
|
290
|
|
|
83
|
|
|
566
|
|
||||
Franchise, excise and other taxes
|
406
|
|
|
93
|
|
|
712
|
|
|
237
|
|
||||
General and administrative
|
1,850
|
|
|
2,325
|
|
|
4,785
|
|
|
5,414
|
|
||||
Loan and realty losses
|
—
|
|
|
—
|
|
|
—
|
|
|
4,037
|
|
||||
|
18,635
|
|
|
8,696
|
|
|
38,072
|
|
|
21,614
|
|
||||
|
|
|
|
|
|
|
|
||||||||
Income before equity-method investee, discontinued operations and noncontrolling interest
|
25,525
|
|
|
18,406
|
|
|
49,224
|
|
|
32,614
|
|
||||
Income from equity-method investee
|
52
|
|
|
70
|
|
|
210
|
|
|
91
|
|
||||
Income from continuing operations
|
25,577
|
|
|
18,476
|
|
|
49,434
|
|
|
32,705
|
|
||||
Income from discontinued operations
|
—
|
|
|
1,622
|
|
|
—
|
|
|
3,316
|
|
||||
Net income
|
25,577
|
|
|
20,098
|
|
|
49,434
|
|
|
36,021
|
|
||||
Less: net income attributable to noncontrolling interest
|
(283
|
)
|
|
(178
|
)
|
|
(606
|
)
|
|
(358
|
)
|
||||
Net income attributable to common stockholders
|
$
|
25,294
|
|
|
$
|
19,920
|
|
|
$
|
48,828
|
|
|
$
|
35,663
|
|
|
|
|
|
|
|
|
|
||||||||
Weighted average common shares outstanding:
|
|
|
|
|
|
|
|
||||||||
Basic
|
33,052,750
|
|
|
27,876,176
|
|
|
33,052,083
|
|
|
27,871,120
|
|
||||
Diluted
|
33,087,283
|
|
|
27,913,727
|
|
|
33,086,258
|
|
|
27,907,600
|
|
||||
Earnings per common share:
|
|
|
|
|
|
|
|
||||||||
Basic:
|
|
|
|
|
|
|
|
||||||||
Income from continuing operations attributable to common stockholders
|
$
|
.77
|
|
|
$
|
.66
|
|
|
$
|
1.48
|
|
|
$
|
1.16
|
|
Discontinued operations
|
—
|
|
|
.05
|
|
|
—
|
|
|
.12
|
|
||||
Net income per common share attributable to common stockholders
|
$
|
.77
|
|
|
$
|
.71
|
|
|
$
|
1.48
|
|
|
$
|
1.28
|
|
Diluted:
|
|
|
|
|
|
|
|
||||||||
Income from continuing operations attributable to common stockholders
|
$
|
.76
|
|
|
$
|
.66
|
|
|
$
|
1.48
|
|
|
$
|
1.15
|
|
Discontinued operations
|
—
|
|
|
.05
|
|
|
—
|
|
|
.12
|
|
||||
Net income per common share attributable to common stockholders
|
$
|
.76
|
|
|
$
|
.71
|
|
|
$
|
1.48
|
|
|
$
|
1.27
|
|
|
Three Months Ended
|
|
Six Months Ended
|
||||||||||||
|
June 30,
|
|
June 30,
|
||||||||||||
|
2014
|
|
2013
|
|
2014
|
|
2013
|
||||||||
|
(unaudited)
|
|
(unaudited)
|
||||||||||||
Net income
|
$
|
25,577
|
|
|
$
|
20,098
|
|
|
$
|
49,434
|
|
|
$
|
36,021
|
|
Other comprehensive income:
|
|
|
|
|
|
|
|
||||||||
Change in unrealized gains (losses) on securities
|
553
|
|
|
(641
|
)
|
|
1,341
|
|
|
1,320
|
|
||||
Increase (decrease) in fair value of cash flow hedge
|
(2,079
|
)
|
|
974
|
|
|
(3,137
|
)
|
|
1,373
|
|
||||
Less: reclassification adjustment for amounts recognized in net income
|
(1,190
|
)
|
|
(137
|
)
|
|
(1,718
|
)
|
|
(266
|
)
|
||||
Total other comprehensive income (loss)
|
(2,716
|
)
|
|
196
|
|
|
(3,514
|
)
|
|
2,427
|
|
||||
Comprehensive income
|
22,861
|
|
|
20,294
|
|
|
45,920
|
|
|
38,448
|
|
||||
Less: comprehensive income attributable to noncontrolling interest
|
(283
|
)
|
|
(178
|
)
|
|
(606
|
)
|
|
(358
|
)
|
||||
Comprehensive income attributable to common stockholders
|
$
|
22,578
|
|
|
$
|
20,116
|
|
|
$
|
45,314
|
|
|
$
|
38,090
|
|
|
Six Months Ended
|
||||||
|
June 30,
|
||||||
|
2014
|
|
2013
|
||||
|
(
unaudited
)
|
||||||
Cash flows from operating activities:
|
|
|
|
||||
Net income
|
$
|
49,434
|
|
|
$
|
36,021
|
|
Adjustments to reconcile net income to net cash provided by
|
|
|
|
||||
operating activities:
|
|
|
|
||||
Depreciation
|
18,777
|
|
|
8,973
|
|
||
Amortization
|
1,081
|
|
|
506
|
|
||
Straight-line rental income
|
(8,490
|
)
|
|
(2,695
|
)
|
||
Write-off of debt issuance costs
|
2,145
|
|
|
353
|
|
||
Loan and realty losses
|
—
|
|
|
4,037
|
|
||
Share-based compensation
|
1,573
|
|
|
1,833
|
|
||
Income from equity-method investee
|
(210
|
)
|
|
(91
|
)
|
||
Change in operating assets and liabilities:
|
|
|
|
||||
Equity-method investment and other assets
|
(381
|
)
|
|
(1,234
|
)
|
||
Accounts payable and accrued expenses
|
177
|
|
|
326
|
|
||
Deferred income
|
(2,486
|
)
|
|
(104
|
)
|
||
Net cash provided by operating activities
|
61,620
|
|
|
47,925
|
|
||
Cash flows from investing activities:
|
|
|
|
||||
Investment in mortgage and other notes receivable
|
(1,214
|
)
|
|
(500
|
)
|
||
Collection of mortgage and other notes receivable
|
999
|
|
|
15,484
|
|
||
Investment in real estate
|
(29,423
|
)
|
|
(83,179
|
)
|
||
Investment in real estate development
|
(3,320
|
)
|
|
(3,905
|
)
|
||
Investment in renovations of existing real estate
|
(2,076
|
)
|
|
(3,336
|
)
|
||
Payment of earnest money deposit
|
—
|
|
|
(2,500
|
)
|
||
Payment of real estate purchase liability
|
(1,600
|
)
|
|
—
|
|
||
Net cash used in investing activities
|
(36,634
|
)
|
|
(77,936
|
)
|
||
Cash flows from financing activities:
|
|
|
|
||||
Net change in borrowings under revolving credit facilities
|
(51,000
|
)
|
|
103,000
|
|
||
Proceeds from convertible senior notes
|
200,000
|
|
|
—
|
|
||
Borrowings on term loan
|
130,000
|
|
|
80,000
|
|
||
Payments on term loans
|
(250,526
|
)
|
|
(80,000
|
)
|
||
Debt issuance costs
|
(7,007
|
)
|
|
(1,231
|
)
|
||
Proceeds from exercise of stock options
|
—
|
|
|
146
|
|
||
Distributions to noncontrolling interest
|
(865
|
)
|
|
(441
|
)
|
||
Dividends paid to stockholders
|
(49,743
|
)
|
|
(44,166
|
)
|
||
Net cash (used in) provided by financing activities
|
(29,141
|
)
|
|
57,308
|
|
||
|
|
|
|
||||
(Decrease) increase in cash and cash equivalents
|
(4,155
|
)
|
|
27,297
|
|
||
Cash and cash equivalents, beginning of period
|
11,312
|
|
|
9,172
|
|
||
Cash and cash equivalents, end of period
|
$
|
7,157
|
|
|
$
|
36,469
|
|
|
Six Months Ended
|
||||||
|
June 30,
|
||||||
|
2014
|
|
2013
|
||||
|
(unaudited)
|
||||||
Supplemental disclosure of cash flow information:
|
|
|
|
||||
Interest paid
|
$
|
8,886
|
|
|
$
|
2,201
|
|
Supplemental disclosure of non-cash investing and financing activities:
|
|
|
|
||||
Tax deferred exchange funds applied to investment in real estate
|
$
|
23,813
|
|
|
$
|
—
|
|
Conditional consideration in asset acquisition
|
$
|
3,000
|
|
|
$
|
1,600
|
|
Accounts payable related to investments in real estate
|
$
|
2,103
|
|
|
$
|
—
|
|
Assumption of debt in real estate acquisition
|
$
|
—
|
|
|
$
|
80,528
|
|
Increase (decrease) in fair value of cash flow hedge
|
$
|
(3,137
|
)
|
|
$
|
1,373
|
|
Assignment of net assets in equity-method investee
|
$
|
—
|
|
|
$
|
817
|
|
|
Common Stock
|
|
Capital in Excess of Par Value
|
|
Cumulative Net Income in Excess of Dividends
|
|
Accumulated Other Comprehensive Income
|
|
Total National Health Investors Stockholders' Equity
|
|
Noncontrolling Interest
|
|
Total Equity
|
|||||||||||||||||
|
Shares
|
|
Amount
|
|
|
|
|
|
|
|||||||||||||||||||||
Balances at December 31, 2013
|
33,051,176
|
|
|
$
|
330
|
|
|
$
|
753,635
|
|
|
$
|
3,043
|
|
|
$
|
9,538
|
|
|
$
|
766,546
|
|
|
$
|
10,614
|
|
|
$
|
777,160
|
|
Total comprehensive income
|
—
|
|
|
—
|
|
|
—
|
|
|
48,828
|
|
|
(3,514
|
)
|
|
45,314
|
|
|
606
|
|
|
45,920
|
|
|||||||
Distributions to noncontrolling interest
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(865
|
)
|
|
(865
|
)
|
|||||||
Shares issued on stock options exercised
|
3,423
|
|
|
1
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
1
|
|
|
—
|
|
|
1
|
|
|||||||
Share-based compensation
|
—
|
|
|
—
|
|
|
1,573
|
|
|
—
|
|
|
—
|
|
|
1,573
|
|
|
—
|
|
|
1,573
|
|
|||||||
Equity component of convertible debt
|
—
|
|
|
—
|
|
|
7,495
|
|
|
—
|
|
|
—
|
|
|
7,495
|
|
|
—
|
|
|
7,495
|
|
|||||||
Dividends declared, $1.54 per common share
|
—
|
|
|
—
|
|
|
—
|
|
|
(50,902
|
)
|
|
—
|
|
|
(50,902
|
)
|
|
—
|
|
|
(50,902
|
)
|
|||||||
Balances at June 30, 2014
|
33,054,599
|
|
|
$
|
331
|
|
|
$
|
762,703
|
|
|
$
|
969
|
|
|
$
|
6,024
|
|
|
$
|
770,027
|
|
|
$
|
10,355
|
|
|
$
|
780,382
|
|
|
Three Months Ended
|
|
Six Months Ended
|
||||||||||||
|
June 30,
|
|
June 30,
|
||||||||||||
|
2014
|
|
2013
|
|
2014
|
|
2013
|
||||||||
Current year
|
$
|
573
|
|
|
$
|
568
|
|
|
$
|
1,139
|
|
|
$
|
1,136
|
|
Prior year final certification
1
|
—
|
|
|
—
|
|
|
15
|
|
|
746
|
|
||||
Total percentage rent income
|
$
|
573
|
|
|
$
|
568
|
|
|
$
|
1,154
|
|
|
$
|
1,882
|
|
|
Three Months Ended
|
|
Six Months Ended
|
||||||||||||
|
June 30,
|
|
June 30,
|
||||||||||||
|
2014
|
|
2013
|
|
2014
|
|
2013
|
||||||||
Revenue
|
$
|
44,160
|
|
|
$
|
29,690
|
|
|
$
|
87,296
|
|
|
$
|
59,404
|
|
Net income
|
$
|
25,605
|
|
|
$
|
20,506
|
|
|
$
|
49,489
|
|
|
$
|
36,847
|
|
Net income available to common stockholders
|
$
|
25,306
|
|
|
$
|
20,267
|
|
|
$
|
48,863
|
|
|
$
|
36,365
|
|
Basic earnings per common share
|
$
|
.77
|
|
|
$
|
.73
|
|
|
$
|
1.48
|
|
|
$
|
1.30
|
|
Diluted earnings per common share
|
$
|
.76
|
|
|
$
|
.73
|
|
|
$
|
1.48
|
|
|
$
|
1.30
|
|
|
June 30,
2014 |
|
December 31,
2013 |
||||
Equity-method investment in OpCo
|
$
|
9,704
|
|
|
$
|
9,494
|
|
Debt issuance costs
|
11,386
|
|
|
7,366
|
|
||
Accounts receivable and other assets
|
1,519
|
|
|
2,502
|
|
||
Replacement reserve and tax escrows - Fannie Mae
|
796
|
|
|
706
|
|
||
Lease escrow deposits
|
22,775
|
|
|
22,775
|
|
||
Escrow deposit for tax deferred exchange
|
—
|
|
|
23,813
|
|
||
|
$
|
46,180
|
|
|
$
|
66,656
|
|
|
June 30, 2014
|
|
December 31, 2013
|
||||||||||||
|
Amortized Cost
|
|
|
Fair Value
|
|
|
Amortized Cost
|
|
|
Fair Value
|
|
||||
Common stock of other healthcare REITs
|
$
|
4,088
|
|
|
$
|
13,991
|
|
|
$
|
4,088
|
|
|
$
|
12,650
|
|
|
June 30,
2014 |
|
December 31,
2013 |
||||
Convertible senior notes - unsecured (net of discount of $7,484)
|
$
|
192,516
|
|
|
$
|
—
|
|
Revolving credit facility - unsecured
|
116,000
|
|
|
167,000
|
|
||
Bank term loans - unsecured
|
250,000
|
|
|
370,000
|
|
||
Fannie Mae term loans - secured (including a premium of $1,705)
|
79,503
|
|
|
80,080
|
|
||
|
$
|
638,019
|
|
|
$
|
617,080
|
|
|
Three Months Ended
|
|
Six Months Ended
|
||||||||||||
|
June 30,
|
|
June 30,
|
||||||||||||
|
2014
|
|
2013
|
|
2014
|
|
2013
|
||||||||
Interest expense at contractual rates
|
$
|
6,065
|
|
|
$
|
1,193
|
|
|
$
|
10,438
|
|
|
$
|
2,235
|
|
Amortization of debt issuance costs and bond discount
|
764
|
|
|
404
|
|
|
1,132
|
|
|
133
|
|
||||
Debt issuance costs expensed due to credit facility modifications
|
—
|
|
|
—
|
|
|
2,145
|
|
|
353
|
|
||||
Total interest expense
|
$
|
6,829
|
|
|
$
|
1,597
|
|
|
$
|
13,715
|
|
|
$
|
2,721
|
|
Date Entered
|
|
Maturity Date
|
|
Fixed Rate
|
|
Rate Index
|
|
Notional Amount
|
|
Fair Value
|
||||
May 2012
|
|
April 2019
|
|
3.29%
|
|
1-month LIBOR
|
|
$
|
40,000
|
|
|
$
|
(39
|
)
|
June 2013
|
|
June 2020
|
|
3.86%
|
|
1-month LIBOR
|
|
$
|
80,000
|
|
|
$
|
(1,333
|
)
|
March 2014
|
|
June 2020
|
|
3.91%
|
|
1-month LIBOR
|
|
$
|
130,000
|
|
|
$
|
(2,508
|
)
|
|
Three Months Ended
|
|
Six Months Ended
|
||||||||||||
|
June 30,
|
|
June 30,
|
||||||||||||
|
2014
|
|
2013
|
|
2014
|
|
2013
|
||||||||
Revenues:
|
|
|
|
|
|
|
|
||||||||
Rental income
|
$
|
—
|
|
|
$
|
1,788
|
|
|
$
|
—
|
|
|
$
|
3,648
|
|
Other income
|
—
|
|
|
1
|
|
|
—
|
|
|
2
|
|
||||
Expenses:
|
|
|
|
|
|
|
|
||||||||
Depreciation
|
—
|
|
|
167
|
|
|
—
|
|
|
334
|
|
||||
Total discontinued operations
|
$
|
—
|
|
|
$
|
1,622
|
|
|
$
|
—
|
|
|
$
|
3,316
|
|
|
|
|
|
|
|
|
|
||||||||
Weighted average common shares outstanding:
|
|
|
|
|
|
|
|
||||||||
Basic
|
33,052,750
|
|
|
27,876,176
|
|
|
33,052,083
|
|
|
27,871,120
|
|
||||
Diluted
|
33,087,283
|
|
|
27,913,727
|
|
|
33,086,258
|
|
|
27,907,600
|
|
||||
|
|
|
|
|
|
|
|
||||||||
Discontinued operations income per share:
|
|
|
|
|
|
|
|
||||||||
Basic
|
$
|
—
|
|
|
$
|
.05
|
|
|
$
|
—
|
|
|
$
|
.12
|
|
Diluted
|
$
|
—
|
|
|
$
|
.05
|
|
|
$
|
—
|
|
|
$
|
.12
|
|
|
Three Months Ended
|
|
Six Months Ended
|
||||||||||||
|
June 30,
|
|
June 30,
|
||||||||||||
|
2014
|
|
2013
|
|
2014
|
|
2013
|
||||||||
Income from continuing operations attributable to common stockholders
|
$
|
25,294
|
|
|
$
|
18,298
|
|
|
$
|
48,828
|
|
|
$
|
32,347
|
|
Discontinued operations
|
—
|
|
|
1,622
|
|
|
—
|
|
|
3,316
|
|
||||
Net income attributable to common stockholders
|
$
|
25,294
|
|
|
$
|
19,920
|
|
|
$
|
48,828
|
|
|
$
|
35,663
|
|
|
|
|
|
|
|
|
|
||||||||
BASIC:
|
|
|
|
|
|
|
|
||||||||
Weighted average common shares outstanding
|
33,052,750
|
|
|
27,876,176
|
|
|
33,052,083
|
|
|
27,871,120
|
|
||||
|
|
|
|
|
|
|
|
||||||||
Income from continuing operations per common share
|
$
|
.77
|
|
|
$
|
.66
|
|
|
$
|
1.48
|
|
|
$
|
1.16
|
|
Discontinued operations per common share
|
—
|
|
|
.05
|
|
|
—
|
|
|
.12
|
|
||||
Net income per common share
|
$
|
.77
|
|
|
$
|
.71
|
|
|
$
|
1.48
|
|
|
$
|
1.28
|
|
|
|
|
|
|
|
|
|
||||||||
DILUTED:
|
|
|
|
|
|
|
|
||||||||
Weighted average common shares outstanding
|
33,052,750
|
|
|
27,876,176
|
|
|
33,052,083
|
|
|
27,871,120
|
|
||||
Stock options
|
34,533
|
|
|
37,551
|
|
|
34,175
|
|
|
36,480
|
|
||||
Average dilutive common shares outstanding
|
33,087,283
|
|
|
27,913,727
|
|
|
33,086,258
|
|
|
27,907,600
|
|
||||
|
|
|
|
|
|
|
|
||||||||
Income from continuing operations per common share
|
$
|
.76
|
|
|
$
|
.66
|
|
|
$
|
1.48
|
|
|
$
|
1.15
|
|
Discontinued operations per common share
|
—
|
|
|
.05
|
|
|
—
|
|
|
.12
|
|
||||
Net income per common share
|
$
|
.76
|
|
|
$
|
.71
|
|
|
$
|
1.48
|
|
|
$
|
1.27
|
|
|
|
|
|
|
|
|
|
||||||||
Incremental shares excluded since anti-dilutive:
|
|
|
|
|
|
|
|
||||||||
Net share effect of stock options with an exercise price in excess of the average market price for our common shares
|
31,575
|
|
|
16,848
|
|
|
31,936
|
|
|
10,100
|
|
||||
|
|
|
|
|
|
|
|
||||||||
Regular dividends declared per common share
|
$
|
.77
|
|
|
$
|
.735
|
|
|
$
|
1.54
|
|
|
$
|
1.43
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair Value Measurement
|
||||||
|
Balance Sheet Classification
|
|
June 30,
2014 |
|
December 31,
2013 |
||||
Level 1
|
|
|
|
|
|
||||
Common stock of other healthcare REITs
|
Marketable securities
|
|
$
|
13,991
|
|
|
$
|
12,650
|
|
|
|
|
|
|
|
||||
Level 2
|
|
|
|
|
|
||||
Interest rate swap asset
|
Other assets
|
|
$
|
—
|
|
|
$
|
975
|
|
Interest rate swap liability
|
Accrued expenses
|
|
$
|
3,880
|
|
|
$
|
—
|
|
|
|
|
|
|
|
||||
Level 3
|
|
|
|
|
|
||||
Contingent consideration
|
Real estate purchase liabilities
|
|
$
|
4,000
|
|
|
$
|
2,600
|
|
|
Fair Value Beginning of Period
|
|
|
Transfers Into Level 3
|
|
|
Realized Gains and (Losses)
|
|
|
Purchases, Issuances and Settlements, net
|
|
|
Fair Value at End of Period
|
|
|
Total Period Losses Included in Earnings Attributable to the Change in Unrealized Losses Relating to Assets Held at End of Year
|
|
||||||
2014
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Contingent consideration
|
$
|
2,600
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
1,400
|
|
|
$
|
4,000
|
|
|
$
|
—
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
2013
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Contingent consideration
|
$
|
4,256
|
|
|
$
|
1,600
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
5,856
|
|
|
$
|
—
|
|
|
Carrying Amount
|
|
Fair Value Measurement
|
||||||||||||
|
2014
|
|
2013
|
|
2014
|
|
2013
|
||||||||
Level 2
|
|
|
|
|
|
|
|
||||||||
Variable rate debt
|
$
|
366,000
|
|
|
$
|
537,000
|
|
|
$
|
366,000
|
|
|
$
|
537,000
|
|
Fixed rate debt
|
$
|
272,019
|
|
|
$
|
80,080
|
|
|
$
|
274,817
|
|
|
$
|
79,365
|
|
|
|
|
|
|
|
|
|
||||||||
Level 3
|
|
|
|
|
|
|
|
||||||||
Mortgage and other notes receivable
|
$
|
60,854
|
|
|
$
|
60,639
|
|
|
$
|
69,025
|
|
|
$
|
67,201
|
|
*
|
We depend on the operating success of our customers (facility operators) for collection of our revenues during this time of uncertain economic conditions in the U.S.;
|
*
|
We are exposed to the risk that our tenants and borrowers may not be able to meet the rent, principal and interest or other payments due us, which may result in an operator bankruptcy or insolvency, or that an operator might become subject to bankruptcy or insolvency proceedings for other reasons;
|
*
|
We are exposed to risks related to governmental regulations and payors, principally Medicare and Medicaid, and the effect that lower reimbursement rates will have on our tenants’ and borrowers’ business;
|
*
|
We are exposed to the risk that the cash flows of our tenants and borrowers will be adversely affected by increased liability claims and general and professional liability insurance costs;
|
*
|
We are exposed to risks related to environmental laws and the costs associated with the liability related to hazardous substances;
|
*
|
We are exposed to the risk that we may not be indemnified by our lessees and borrowers against future litigation;
|
*
|
We depend on the success of future acquisitions and investments;
|
*
|
We depend on the ability to reinvest cash in real estate investments in a timely manner and on acceptable terms;
|
*
|
We may need to incur more debt in the future, which may not be available on terms acceptable to the Company;
|
*
|
We have covenants related to our indebtedness which impose certain operational limitations and a breach of those covenants could materially adversely affect our financial condition and results of operations;
|
*
|
We are exposed to the risk that the illiquidity of real estate investments could impede our ability to respond to adverse changes in the performance of our properties;
|
*
|
We are exposed to risks associated with our investments in unconsolidated entities, including our lack of sole decision-making authority and our reliance on the financial condition of other interests;
|
*
|
We depend on revenues derived mainly from fixed rate investments in real estate assets, while our debt capital used to finance those investments is primarily at variable rates. This circumstance creates interest rate risk to the Company;
|
*
|
We are exposed to the risk that our assets may be subject to impairment charges;
|
*
|
We depend on the ability to continue to qualify as a real estate investment trust;
|
*
|
We have ownership limits in our charter with respect to our common stock and other classes of capital stock which may delay, defer or prevent a transaction or a change of control that might involve a premium price for our common stock or might otherwise be in the best interests of our stockholders;
|
*
|
We are subject to certain provisions of Maryland law and our charter and bylaws that could hinder, delay or prevent a change in control transaction, even if the transaction involves a premium price for our common stock or our stockholders believe such transaction to be otherwise in their best interests.
|
Real Estate Properties
|
Properties
|
|
|
Beds/Sq. Ft.*
|
|
|
Revenue
|
|
|||
|
Assisted Living
|
60
|
|
|
3,018
|
|
|
$
|
19,320
|
|
|
|
Senior Living Campus
|
5
|
|
|
797
|
|
|
3,487
|
|
||
|
Independent Living
|
28
|
|
|
3,114
|
|
|
22,564
|
|
||
|
Senior Housing Communities
|
93
|
|
|
6,929
|
|
|
45,371
|
|
||
|
Skilled Nursing Facilities
|
64
|
|
|
8,370
|
|
|
32,050
|
|
||
|
Hospitals
|
3
|
|
|
181
|
|
|
3,759
|
|
||
|
Medical Office Buildings
|
2
|
|
|
88,517
|
|
*
|
486
|
|
||
|
|
Total Real Estate Properties
|
162
|
|
|
|
|
$
|
81,666
|
|
|
|
|
|
|
|
|
|
|
||||
Mortgage and Other Notes Receivable
|
|
|
|
|
|
||||||
|
Assisted Living
|
3
|
|
|
310
|
|
|
$
|
503
|
|
|
|
Senior Living Campus
|
—
|
|
|
76
|
|
|
30
|
|
||
|
Senior Housing Communities
|
3
|
|
|
386
|
|
|
533
|
|
||
|
Skilled Nursing Facilities
|
7
|
|
|
594
|
|
|
696
|
|
||
|
Hospital
|
1
|
|
|
70
|
|
|
597
|
|
||
|
Other Notes Receivable
|
—
|
|
|
—
|
|
|
1,678
|
|
||
|
|
Total Mortgage and Other Notes Receivable
|
11
|
|
|
|
|
$
|
3,504
|
|
|
|
|
Total Portfolio
|
173
|
|
|
|
|
$
|
85,170
|
|
Portfolio Summary
|
Properties
|
|
|
Investment %
|
|
|
Revenue
|
||||
|
Real Estate Properties
|
162
|
|
|
95.9
|
%
|
|
$
|
81,666
|
|
|
|
Mortgage and Other Notes Receivable
|
11
|
|
|
4.1
|
%
|
|
3,504
|
|
||
|
|
Total Portfolio
|
173
|
|
|
100.0
|
%
|
|
$
|
85,170
|
|
|
|
|
|
|
|
|
|
||||
Summary of Facilities by Type
|
|
|
|
|
|
||||||
|
Assisted Living
|
63
|
|
|
23.3
|
%
|
|
$
|
19,823
|
|
|
|
Independent Living
|
28
|
|
|
26.5
|
%
|
|
22,564
|
|
||
|
Senior Living Campus
|
5
|
|
|
4.1
|
%
|
|
3,517
|
|
||
|
Senior Housing Communities
|
96
|
|
|
53.9
|
%
|
|
45,904
|
|
||
|
Skilled Nursing Facilities
|
71
|
|
|
38.4
|
%
|
|
32,746
|
|
||
|
Hospitals
|
4
|
|
|
5.1
|
%
|
|
4,356
|
|
||
|
Medical Office Buildings
|
2
|
|
|
0.6
|
%
|
|
486
|
|
||
|
Other
|
—
|
|
|
2.0
|
%
|
|
1,678
|
|
||
|
|
Total Real Estate Portfolio
|
173
|
|
|
100.0
|
%
|
|
$
|
85,170
|
|
|
|
|
|
|
|
|
|
||||
Portfolio by Operator Type
|
|
|
|
|
|
||||||
|
Public
|
53
|
|
|
26.8
|
%
|
|
$
|
22,821
|
|
|
|
National Chain (Privately-Owned)
|
29
|
|
|
29.1
|
%
|
|
24,753
|
|
||
|
Regional
|
81
|
|
|
39.0
|
%
|
|
33,233
|
|
||
|
Small
|
10
|
|
|
5.1
|
%
|
|
4,363
|
|
||
|
|
Total Real Estate Portfolio
|
173
|
|
|
100.0
|
%
|
|
$
|
85,170
|
|
|
YTD 2014
|
|
2013
|
|
2012
|
|
2011
|
|
2010
|
||||||||||
Regular
|
$
|
1.54
|
|
|
$
|
2.90
|
|
|
$
|
2.64
|
|
|
$
|
2.50
|
|
|
$
|
2.36
|
|
Special
|
—
|
|
|
$
|
—
|
|
|
$
|
0.22
|
|
1
|
$
|
0.22
|
|
|
$
|
—
|
|
|
|
$
|
1.54
|
|
|
$
|
2.90
|
|
|
$
|
2.86
|
|
|
$
|
2.72
|
|
|
$
|
2.36
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
|
Six Months Ended
|
||||||||||||
|
June 30,
|
|
June 30,
|
||||||||||||
|
2014
|
|
2013
|
|
2014
|
|
2013
|
||||||||
Current year
|
$
|
573
|
|
|
$
|
568
|
|
|
$
|
1,139
|
|
|
$
|
1,136
|
|
Prior year final certification
1
|
—
|
|
|
—
|
|
|
15
|
|
|
746
|
|
||||
Total percentage rent income
|
$
|
573
|
|
|
$
|
568
|
|
|
$
|
1,154
|
|
|
$
|
1,882
|
|
|
Three Months Ended
|
|
Six Months Ended
|
||||||||||||
|
June 30,
|
|
June 30,
|
||||||||||||
|
2014
|
|
2013
|
|
2014
|
|
2013
|
||||||||
Revenues
|
$
|
15,839
|
|
|
$
|
6,131
|
|
|
$
|
31,715
|
|
|
$
|
12,320
|
|
|
|
|
|
|
|
|
|
||||||||
Operating expenses, including management fees
|
10,450
|
|
|
3,938
|
|
|
20,753
|
|
|
7,994
|
|
||||
Lease expenses
|
5,202
|
|
|
2,093
|
|
|
10,465
|
|
|
4,174
|
|
||||
Depreciation and amortization
|
125
|
|
|
18
|
|
|
250
|
|
|
45
|
|
||||
Net Income
|
$
|
62
|
|
|
$
|
82
|
|
|
$
|
247
|
|
|
$
|
107
|
|
|
Three Months Ended
|
|
|
|
|
|||||||||
|
June 30,
|
|
Period Change
|
|||||||||||
|
2014
|
|
2013
|
|
$
|
|
%
|
|||||||
Revenues:
|
|
|
|
|
|
|
|
|||||||
Rental income
|
|
|
|
|
|
|
|
|||||||
ILFs leased to an affiliate of Holiday Retirement
|
$
|
7,979
|
|
|
$
|
—
|
|
|
$
|
7,979
|
|
|
NM
|
|
ALFs leased to RIDEA joint venture with Bickford
|
5,089
|
|
|
2,084
|
|
|
3,005
|
|
|
144.2
|
%
|
|||
SNFs newly leased to NHC (7 ElderTrust facilities)
|
863
|
|
|
—
|
|
|
863
|
|
|
NM
|
|
|||
3 SNFs and 1 ALF leased to Prestige Senior Living
|
845
|
|
|
—
|
|
|
845
|
|
|
NM
|
|
|||
SNFs leased to Fundamental
|
1,388
|
|
|
940
|
|
|
448
|
|
|
47.7
|
%
|
|||
ALFs leased to Senior Living
|
1,224
|
|
|
911
|
|
|
313
|
|
|
34.4
|
%
|
|||
Other new and existing leases
|
19,670
|
|
|
18,738
|
|
|
932
|
|
|
5.0
|
%
|
|||
|
37,058
|
|
|
22,673
|
|
|
14,385
|
|
|
63.4
|
%
|
|||
Straight-line rent adjustments, new and existing leases
|
4,295
|
|
|
1,394
|
|
|
2,901
|
|
|
NM
|
|
|||
Total Rental Income
|
41,353
|
|
|
24,067
|
|
|
17,286
|
|
|
71.8
|
%
|
|||
Interest income from mortgage and other notes
|
|
|
|
|
|
|
|
|||||||
Bickford Senior Living
|
279
|
|
|
—
|
|
|
279
|
|
|
NM
|
|
|||
ElderTrust
|
—
|
|
|
240
|
|
|
(240
|
)
|
|
NM
|
|
|||
SeniorTrust
|
—
|
|
|
229
|
|
|
(229
|
)
|
|
NM
|
|
|||
Other new and existing mortgages
|
1,469
|
|
|
1,503
|
|
|
(34
|
)
|
|
(2.3
|
)%
|
|||
Total Interest Income from Mortgage and Other Notes
|
1,748
|
|
|
1,972
|
|
|
(224
|
)
|
|
(11.4
|
)%
|
|||
Investment income and other
|
1,059
|
|
|
1,063
|
|
|
(4
|
)
|
|
(0.4
|
)%
|
|||
Total Revenue
|
44,160
|
|
|
27,102
|
|
|
17,058
|
|
|
62.9
|
%
|
|||
Expenses:
|
|
|
|
|
|
|
|
|||||||
Depreciation
|
|
|
|
|
|
|
|
|||||||
ILFs leased to an affiliate of Holiday Retirement
|
3,229
|
|
|
—
|
|
|
3,229
|
|
|
NM
|
|
|||
ALFs leased to RIDEA joint venture with Bickford
|
1,649
|
|
|
582
|
|
|
1,067
|
|
|
183.3
|
%
|
|||
SNFs newly leased to NHC (7 ElderTrust facilities)
|
224
|
|
|
—
|
|
|
224
|
|
|
NM
|
|
|||
Other new and existing assets
|
4,438
|
|
|
3,809
|
|
|
629
|
|
|
16.5
|
%
|
|||
Total Depreciation
|
9,540
|
|
|
4,391
|
|
|
5,149
|
|
|
117.3
|
%
|
|||
Interest expense and amortization of debt issuance costs
|
6,829
|
|
|
1,597
|
|
|
5,232
|
|
|
327.6
|
%
|
|||
Legal
|
10
|
|
|
290
|
|
|
(280
|
)
|
|
NM
|
|
|||
Franchise, excise and other taxes
|
406
|
|
|
93
|
|
|
313
|
|
|
336.6
|
%
|
|||
Other expenses
|
1,850
|
|
|
2,325
|
|
|
(475
|
)
|
|
(20.4
|
)%
|
|||
|
18,635
|
|
|
8,696
|
|
|
9,939
|
|
|
114.3
|
%
|
|||
Income before equity-method investee, discontinued operations and noncontrolling interest
|
25,525
|
|
|
18,406
|
|
|
7,119
|
|
|
38.7
|
%
|
|||
Income from equity-method investee
|
52
|
|
|
70
|
|
|
(18
|
)
|
|
NM
|
|
|||
Income from continuing operations
|
25,577
|
|
|
18,476
|
|
|
7,101
|
|
|
38.4
|
%
|
|||
Income from discontinued operations
|
—
|
|
|
1,622
|
|
|
(1,622
|
)
|
|
NM
|
|
|||
Net income
|
25,577
|
|
|
20,098
|
|
|
5,479
|
|
|
27.3
|
%
|
|||
Net income attributable to noncontrolling interest
|
(283
|
)
|
|
(178
|
)
|
|
(105
|
)
|
|
NM
|
|
|||
Net income attributable to common stockholders
|
$
|
25,294
|
|
|
$
|
19,920
|
|
|
$
|
5,374
|
|
|
27.0
|
%
|
|
|
|
|
|
|
|
|
|||||||
NM - not meaningful
|
|
|
|
|
|
|
|
•
|
Rental income increased
$17,286,000
primarily as a result of new real estate investments. During 2013 we completed $748,939,000 of new real estate investments. For the six months ended June 30, 2014, we have funded $58,632,000 of new real estate investments. The increase in rental income included a
$2,901,000
increase in straight-line rent adjustments. Generally accepted accounting principles require rental income to be recognized on a straight-line basis over the term of the lease to give effect to scheduled rent escalators. Future increases in rental income depend on our ability to make new investments which meet our underwriting criteria.
|
•
|
Interest income from mortgage and other notes decreased
$224,000
primarily due to the settlement of outstanding notes receivable balances from ElderTrust and SeniorTrust, partially offset by interest income on a note receivable from Bickford Senior Living which began in July 2013. Unless we continue to make new investments in loans, our interest income will continue to decrease due to the normal amortization and scheduled maturities of our loans.
|
•
|
Depreciation expense recognized in continuing operations increased
$5,149,000
compared to the prior year primarily due to new real estate investments completed since June 2013.
|
•
|
Interest expense relates to borrowings on our credit facility, the convertible senior notes issued in March 2014 and debt assumed in the acquisition of real estate. Upfront fees and other debt-related costs are amortized over the term of the credit facility. The increase in interest expense and amortization of debt issuance costs of
$5,232,000
resulted from (a) the issuance of 3.25% coupon convertible debt of $200,000,000 to reduce lower interest borrowings on our revolving credit facility, and (b) expanded borrowings used to fund new real estate investments in 2013. We expect to fund additional healthcare real estate investments in 2014 with borrowings from our bank credit facility and longer-term debt, both secured and unsecured, which will increase our interest expense.
|
•
|
Legal expenses were
$280,000
lower in 2014 when compared to 2013 as a result of litigation which reached final settlement in April 2013.
|
•
|
Franchise, excise and other taxes during the second quarter of 2014 were
$313,000
higher than the same period in 2013 due to the growth in our portfolio and adjustment to our quarterly tax accrual.
|
•
|
Other expenses in 2013 included certain one-time charges totaling $458,000 which did not recur in 2014.
|
•
|
Rental income increased
$33,494,000
primarily as a result of new real estate investments. During 2013 we completed $748,939,000 of new real estate investments. For the six months ended June 30, 2014, we have funded $58,632,000 of new real estate investments. The increase in rental income included a
$5,848,000
increase in straight-line rent adjustments. Generally accepted accounting principles require rental income to be recognized on a straight-line basis over the term of the lease to give effect to scheduled rent escalators. Future increases in rental income depend on our ability to make new investments which meet our underwriting criteria.
|
•
|
Interest income from mortgage and other notes decreased
$437,000
primarily due to the settlement of outstanding notes receivable balances from ElderTrust and SeniorTrust, partially offset by interest income on a note receivable from Bickford Senior Living which began in July 2013. Unless we continue to make new investments in loans, our interest income will continue to decrease due to the normal amortization and scheduled maturities of our loans.
|
•
|
Depreciation expense recognized in continuing operations increased
$10,138,000
compared to the prior year primarily due to new real estate investments completed since June 2013.
|
•
|
Interest expense relates to borrowings on our credit facility, the convertible senior notes issued in March 2014 and debt assumed in the acquisition of real estate. During the first quarter of 2014, we made modifications to our credit facility and as a result have written off
$2,145,000
of previously unamortized debt issuance costs. Upfront fees and other debt-related costs are amortized over the term of the credit facility. The increase in interest expense and amortization of debt issuance costs of
$9,202,000
resulted from (a) the issuance of 3.25% coupon convertible debt of $200,000,000 to reduce lower interest borrowings on our revolving credit facility, and (b) expanded borrowings used to fund new real estate investments in 2013. We expect to fund additional healthcare real estate investments in 2014 with borrowings from our bank credit facility and longer-term debt, both secured and unsecured, which will increase our interest expense.
|
•
|
Legal expenses were
$483,000
lower in 2014 when compared to 2013 as a result of litigation which reached final settlement in April 2013.
|
•
|
Franchise, excise and other taxes during the second quarter of 2014 were
$475,000
higher than the same period in 2013 due to the growth in our portfolio and adjustment to our quarterly tax accrual.
|
•
|
During 2013 we recorded an impairment of $4,037,000 related to a mortgage note due from SeniorTrust.
|
•
|
Other expenses in 2013 included certain one-time charges totaling $458,000 which did not recur in 2014.
|
|
Six Months Ended June 30,
|
|
One Year Change
|
|||||||||||
|
2014
|
|
2013
|
|
$
|
|
%
|
|||||||
Cash and cash equivalents at beginning of period
|
$
|
11,312
|
|
|
$
|
9,172
|
|
|
$
|
2,140
|
|
|
23.3
|
%
|
Net cash provided by operating activities
|
61,620
|
|
|
47,925
|
|
|
13,695
|
|
|
28.6
|
%
|
|||
Net cash used in investing activities
|
(36,634
|
)
|
|
(77,936
|
)
|
|
41,302
|
|
|
(53.0
|
)%
|
|||
Net cash (used in) provided by financing activities
|
(29,141
|
)
|
|
57,308
|
|
|
(86,449
|
)
|
|
NM
|
|
|||
Cash and cash equivalents at end of period
|
$
|
7,157
|
|
|
$
|
36,469
|
|
|
$
|
(29,312
|
)
|
|
(80.4
|
)%
|
Date Entered
|
|
Maturity Date
|
|
Fixed Rate
|
|
Rate Index
|
|
Notional Amount
|
|
Fair Value
|
||||
May 2012
|
|
April 2019
|
|
3.29%
|
|
1-month LIBOR
|
|
$
|
40,000
|
|
|
$
|
(39
|
)
|
June 2013
|
|
June 2020
|
|
3.86%
|
|
1-month LIBOR
|
|
$
|
80,000
|
|
|
$
|
(1,333
|
)
|
March 2014
|
|
June 2020
|
|
3.91%
|
|
1-month LIBOR
|
|
$
|
130,000
|
|
|
$
|
(2,508
|
)
|
|
Total
|
|
Less than 1 year
|
|
1-3 years
|
|
3-5 years
|
|
More than 5 years
|
||||||||||
Debt, including interest
1
|
$
|
764,338
|
|
|
$
|
12,773
|
|
|
$
|
118,071
|
|
|
$
|
38,126
|
|
|
$
|
595,368
|
|
Real estate purchase liabilities
|
4,000
|
|
|
4,000
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
Construction commitments
|
13,314
|
|
|
13,314
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
Loan commitments
|
2,416
|
|
|
2,416
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
|
$
|
784,068
|
|
|
$
|
32,503
|
|
|
$
|
118,071
|
|
|
$
|
38,126
|
|
|
$
|
595,368
|
|
|
Three Months Ended
|
|
Six Months Ended
|
||||||||||||
|
June 30,
|
|
June 30,
|
||||||||||||
|
2014
|
|
2013
|
|
2014
|
|
2013
|
||||||||
Net income
|
$
|
25,577
|
|
|
$
|
20,098
|
|
|
$
|
49,434
|
|
|
$
|
36,021
|
|
Interest expense and amortization of debt issuance costs
|
6,829
|
|
|
1,597
|
|
|
11,570
|
|
|
2,368
|
|
||||
Franchise, excise and other taxes
|
406
|
|
|
93
|
|
|
712
|
|
|
237
|
|
||||
Depreciation in continuing and discontinued operations
|
9,540
|
|
|
4,558
|
|
|
18,777
|
|
|
8,973
|
|
||||
Debt issuance costs expensed due to credit facility modifications
|
—
|
|
|
353
|
|
|
2,145
|
|
|
353
|
|
||||
Acquisition costs under business combination accounting
|
—
|
|
|
208
|
|
|
—
|
|
|
208
|
|
||||
Loan impairment
|
—
|
|
|
—
|
|
|
—
|
|
|
4,037
|
|
||||
Adjusted EBITDA
|
$
|
42,352
|
|
|
$
|
26,907
|
|
|
$
|
82,638
|
|
|
$
|
52,197
|
|
|
|
|
|
|
|
|
|
||||||||
Interest expense
|
$
|
6,829
|
|
|
$
|
1,597
|
|
|
$
|
11,570
|
|
|
$
|
2,368
|
|
Principal payments
|
251
|
|
|
—
|
|
|
526
|
|
|
—
|
|
||||
Fixed Charges
|
$
|
7,080
|
|
|
$
|
1,597
|
|
|
$
|
12,096
|
|
|
$
|
2,368
|
|
|
|
|
|
|
|
|
|
||||||||
Fixed Charge Coverage
|
6:1
|
|
17:1
|
|
7:1
|
|
22:1
|
Exhibit No.
|
Description
|
3.1
|
Articles of Incorporation (incorporated by reference to Exhibit 3.1 to Form S-11 Registration Statement No. 33-41863)
|
|
|
3.2
|
Amendment to Articles of Incorporation (incorporated by reference to Exhibit A to the Company's Definitive Proxy Statement filed March 23, 2009)
|
|
|
3.3
|
Amendment to Articles of Incorporation approved by shareholders on May 2, 2014
|
|
|
3.4
|
Restated Bylaws (incorporated by reference to Exhibit 3.3 to Form 10-K filed February 15, 2013)
|
|
|
3.5
|
Amendment No. 1 to Restated Bylaws dated February 14, 2014 (incorporated by reference to Exhibit 3.4 to Form 10-K filed February 14, 2014)
|
|
|
4.1
|
Form of Common Stock Certificate (Incorporated by reference to Exhibit 39 to Form S-11 Registration Statement No. 33-41863)
|
|
|
4.2
|
Indenture, dated as of March 25, 2014, between National Health Investors, Inc. and The Bank of New York Mellon Trust Company, N.A., as Trustee (incorporated by reference to Exhibit 4.1 to Form 8-K filed March 31, 2014)
|
|
|
4.3
|
First Supplemental Indenture, dated as of March 25, 2014, to the Indenture, dated as of March 25, 2014, between National Health Investors, Inc. and The Bank of New York Mellon Trust Company, N.A., as Trustee(incorporated by reference to Exhibit 4.2 to Form 8-K filed March 31, 2014)
|
|
|
31.1
|
Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|
|
|
31.2
|
Certification of Principal Financial Officer pursuant to 18 U.S.C Section 1350, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|
|
|
32
|
Certification of Chief Executive Officer and Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|
|
|
**101.INS
|
XBRL Instance Document
|
|
|
**101.SCH
|
XBRL Taxonomy Extension Schema Document
|
|
|
**101.CAL
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
|
|
**101.LAB
|
XBRL Taxonomy Extension Label Linkbase Document
|
|
|
**101.PRE
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
|
|
**101.DEF
|
XBRL Taxonomy Extension Definition Linkbase Document
|
|
|
NATIONAL HEALTH INVESTORS, INC.
|
|
|
(Registrant)
|
|
||
|
||
Date:
|
August 1, 2014
|
/s/ J. Justin Hutchens
|
|
|
J. Justin Hutchens
|
|
|
President, Chief Executive Officer,
|
|
|
and Director
|
|
||
|
||
|
||
Date:
|
August 1, 2014
|
/s/ Roger R. Hopkins
|
|
|
Roger R. Hopkins
|
|
|
Chief Accounting Officer
|
|
|
(Principal Financial Officer and Principal Accounting Officer)
|
1.
|
I have reviewed this quarterly report on Form 10-Q of the registrant, National Health Investors, Inc.;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
a.
|
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
b.
|
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
c.
|
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
d.
|
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
|
5.
|
The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
|
a.
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
|
b.
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
|
Date:
|
August 1, 2014
|
/s/ J. Justin Hutchens
|
|
|
J. Justin Hutchens
|
|
|
President, Chief Executive Officer,
|
|
|
and Director
|
1.
|
I have reviewed this quarterly report on Form 10-Q of the registrant, National Health Investors, Inc.;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
a.
|
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
b.
|
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
c.
|
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
d.
|
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
|
5.
|
The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions) :
|
a.
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
|
b.
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
|
Date:
|
August 1, 2014
|
/s/ Roger R. Hopkins
|
|
|
Roger R. Hopkins
|
|
|
Chief Accounting Officer
|
|
|
(Principal Financial Officer and Principal Accounting Officer)
|
(a)
|
The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
|
(b)
|
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Issuer.
|
Date:
|
August 1, 2014
|
/s/ J. Justin Hutchens
|
|
|
J. Justin Hutchens
|
|
|
President, Chief Executive Officer,
|
|
|
and Director
|
|
||
|
||
|
||
Date:
|
August 1, 2014
|
/s/ Roger R. Hopkins
|
|
|
Roger R. Hopkins
|
|
|
Chief Accounting Officer
|
|
|
(Principal Financial Officer and Principal Accounting Officer)
|